Stähler to evaluate Amoéba biocontrol and biocide products

Amoéba, a French producer of a biological biocide capable of eliminating the risk in water and human wounds, and of a biocontrol product for plant protection, still in the testing phase, has signed a Material Transfer Agreement (MTA) with Stähler Suisse SA.

This partnership with one of the major distributors of plant protection products and biocontrol solutions in Switzerland, aims to extend the performance assessment of Amoéba's biocontrol products on grapes and potatoes.

The purpose of the research partnership is the delivery by Amoeba of experimental products containing the amoeba lysate Willaertia magna C2c Maky. In return, Stähler will carry out its own field trials in order to assess the performance of these products in preventing essential diseases specific to the crops tested.

The two companies are starting a targeted research phase which could lead to the commercial development of Amoéba's biocontrol solutions if it proves to be successful. 

"Our market is in demand for innovative crop protection solutions that are both effective and environmentally friendly. This is the case with Amoéba's biocontrol products and Stähler hopes to extend this partnership to other promising solutions for tomorrow's agriculture," said Simon Gasser, Head of Development and Registration at Stähler.

"Amoéba's closer ties with the major players in crop protection, such as Stähler Suisse SA, are part of Amoéba's development strategy for its biocontrol business. These trials offer significant potential for the company and are an essential step towards a possible commercial partnership," explained Fabrice Plasson, Chairman and CEO of Amoéba.

Amoéba has reiterated that the company is still in the testing phase for its biocide and biocontrol applications and does not currently market any products.

Back to Homepage

Back to Healthcare